Puzheng Pharmaceutical

Puzheng Pharmaceutical is a China-based pharmaceutical enterprise specializing in the research, development, and manufacturing of modern Traditional Chinese Medicine (TCM) and natural medicines. Headquartered in Jiangxi Province, the company has established a strong market presence in therapeutic areas such as women's health, pediatrics, and respiratory medicine. Its flagship products, including Ru Kang Qin for breast hyperplasia and Hong Hua Xiao Yao for gynecological health, are recognized for integrating traditional herbal formulas with modern clinical evidence. Puzheng operates several high-tech manufacturing facilities and has been designated as a national high-tech enterprise in China. The company focuses on the sustainable development of botanical resources and the modernization of natural drug delivery systems.